Clinical Trial Update: Effect of MK0524A on Cholesterol Levels (0524A-048) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating MK0524A's effect on cholesterol levels in patients with hypercholesterolemia and hyperlipidemia; the study has completed and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• MK0524A

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypercholesterolemia, Hyperlipidemia | Phase 3 | Status: COMPLETED | Results posted: 2009-05-13